Literature DB >> 9790424

Early electrocardiographic abnormalities in Trypanosoma cruzi-seropositive children.

A L de Andrade1, F Zicker, A Rassi, A G Rassi, R M Oliveira, S A Silva, S S de Andrade, C M Martelli.   

Abstract

As part of a major epidemiologic study on Chagas' disease, we compared the prevalence of electrocardiographic (ECG) abnormalities among 141 school children 7-12 years of age and seropositive for Trypanosoma cruzi, and 282 age-, sex-, and school-matched seronegative children in an endemic area in Brazil. The prevalence of ECG abnormalities was 11.3% among seropositive children and 3.5% among seronegative children (odds ratio = 3.5, 95% confidence interval [CI] = 1.5-8.4). The prevalence rate of ECG alterations was 10.7% for seropositive males versus 8.9% for seropositive females. Complete right bundle branch block (CRBBB), which is highly suggestive of Chagas' disease cardiopathy, was diagnosed in nine (6.4%) seropositive children and in only one (0.3%) seronegative child (odds ratio = 18.5, 95% CI = 2.3-146.5, attributable fraction = 58.3%). Five incident new cases of CRBBB were diagnosed after a 36-month follow-up of seropositive children who were enrolled in an independent clinical field trial. No case of frequent and/or multifocal ventricular premature beats was found in the cohort of children. The surprisingly high frequency of early ECG abnormalities, which indicates a rapid evolution from infection to disease, suggests the existence of endemic areas with a particular accelerated disease progression that was not described before. Under such conditions, a public health chemotherapy program focusing on the treatment of young seropositive children would be recommended.

Entities:  

Mesh:

Year:  1998        PMID: 9790424     DOI: 10.4269/ajtmh.1998.59.530

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.

Authors:  Milagros Corrales; Rubén Cardozo; María Asunción Segura; Julio A Urbina; Miguel Angel Basombrío
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Autonomic dysfunction and risk factors associated with Trypanosoma cruzi infection among children in Arequipa, Peru.

Authors:  Natalie M Bowman; Vivian Kawai; Robert H Gilman; Cesar Bocangel; Gerson Galdos-Cardenas; Lilia Cabrera; Michael Z Levy; Juan Geny Cornejo del Carpio; Freddy Delgado; Lauren Rosenthal; Vivian V Pinedo-Cancino; Francis Steurer; Amy E Seitz; James H Maguire; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

3.  Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.

Authors:  Romina A Cutrullis; Guillermo F Moscatelli; Samanta Moroni; Bibiana J Volta; Rita L Cardoni; Jaime M Altcheh; Ricardo S Corral; Héctor L Freilij; Patricia B Petray
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

4.  Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.

Authors:  Fiorella Bianchi; Zulma Cucunubá; Felipe Guhl; Nadia Lorena González; Hector Freilij; Rubén Santiago Nicholls; Juan David Ramírez; Marleny Montilla; Astrid Carolina Flórez; Fernando Rosas; Victor Saavedra; Nubia Silva
Journal:  PLoS Negl Trop Dis       Date:  2015-02-27

5.  Negativation of Trypanosoma cruzi PCR within Six Months after Treatment of a Child with Nifurtimox.

Authors:  Lauren Pull; Feriel Touafek; Luc Paris; Guillaume Le Loup; Laurent Brutus; Jean-Yves Siriez
Journal:  PLoS Negl Trop Dis       Date:  2015-05-07

6.  Targeted screening strategies to detect Trypanosoma cruzi infection in children.

Authors:  Michael Z Levy; Vivian Kawai; Natalie M Bowman; Lance A Waller; Lilia Cabrera; Viviana V Pinedo-Cancino; Amy E Seitz; Frank J Steurer; Juan G Cornejo del Carpio; Eleazar Cordova-Benzaquen; James H Maguire; Robert H Gilman; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2007-12-26

Review 7.  Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis.

Authors:  Lyda Z Rojas; Marija Glisic; Laura Pletsch-Borba; Luis E Echeverría; Wichor M Bramer; Arjola Bano; Najada Stringa; Asija Zaciragic; Bledar Kraja; Eralda Asllanaj; Rajiv Chowdhury; Carlos A Morillo; Oscar L Rueda-Ochoa; Oscar H Franco; Taulant Muka
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

8.  Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis.

Authors:  Sindhu Chadalawada; Stefan Sillau; Solana Archuleta; William Mundo; Mehdi Bandali; Gabriel Parra-Henao; Alfonso J Rodriguez-Morales; Wilmer E Villamil-Gomez; José Antonio Suárez; Leland Shapiro; Peter J Hotez; Laila Woc-Colburn; Kristen DeSanto; Anis Rassi; Carlos Franco-Paredes; Andrés F Henao-Martínez
Journal:  JAMA Netw Open       Date:  2020-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.